• About us
  • Team
  • Advisory Board
  • Approach
  • Portfolio
  • Partners
  • News
  • Newsletter
  • Contact

News

Bionova Capital’s portfolio company Delox secures € 750,000

  • Press Release
  • May 18, 2022

Recent News

Bionova Capital’s portfolio company Adapttech raises £2.3 million and launches new prosthetic-fitting technologies

Apr 06, 2022

Bionova Capital announces new Scientific Advisory Board

Jun 01, 2021

Adapttech’s CEO Frederico Carpinteiro named to Forbes 30 under 30

Apr 12, 2021

Bionova Capital’s portfolio company Adapttech secures £2.0 million

Mar 24, 2021

Bionova Capital invests in Vaxdyn to develop a new vaccine against deadly bacteria

Mar 08, 2021

Hovione Capital becomes Bionova Capital and expands focus

Feb 1, 2021

Hovione Capital-backed startup Anybrain secures €1.0 million in funding

Mar 30, 2020

Hovione Capital and Portugal Ventures invest in CellmAbs, a Startup developing novel cancer therapies

Nov 13, 2019

Hovione Capital organized the largest-ever Healthcare Investor Conference in Portugal

Nov 08, 2019

Hovione Capital organizes the largest-ever Healthcare Investor Conference in Portugal

Sep 19, 2019

i3S-Hovione Capital Healthcare Innovation Prize

Mar 20, 2019

Hovione Capital appoints Dr. Ricardo Perdigão Henriques as CEO

Feb 01, 2019

Will chronic wounds have a better treatment? SolasCure, a new company in Hovione Capital’s portfolio

Aug 31, 2018

Delox: a unique technology for bio-decontamination and a new company in Hovione Capital’s portfolio

Jun 22, 2018

Adapttech: born in Portugal, raised in Europe and growing globally after securing £1.3M round!

Apr 04, 2018

Bionova Capital SCR, SA

Estrada do Paço do Lumiar
Campus do Lumiar, Edifício R
1649-038 Lisboa, Portugal

Phone: +351 21 982 93 60

© Copyright Bionova Capital. All Rights Reserved